Complex analysis of association of inflammation gene polymorphisms with myocardial infarction

Molecular Biology

Volumn 44, Issue 3, 2010, Pages 407-414

  Sudomoina, M A ^a,b   Sukhinina, T S ^a   Barsova, R M ^a,b   Favorov, A V ^c,d   Sakhnovich, R M ^a   Titov, B V ^a,b   Matveeva, N A ^a,b   Rybalkin, I N ^a   Vlasik, T N ^a   Ochs, M F ^d   Ruda, M Ya ^a   Favorova, O O ^a,b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allelic polymorphism; APSampler; Cytokines; DNA; Genes; Human; Inflammation; Myocardial infarction; Polymerase chain reaction; Russians

Indexed keywords

EID: 77954151257     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893310030088     Document Type: Article

References (47)

1. Shevchenko O. P., Mishnev O. D. 2005. Ishemicheskaya bolezn' serdtsa (Ischemic Heart Disease). Moscow: Reafarm.
2. Ross R. 1999. Atherosclerosis is an inflammatory disease. Am. Heart J. 138, S419-S420.
3. Tabas I. 2009. Macrophage death and defective inflammation resolution in atherosclerosis. Nature Rev. Immunol. 10, 36-46.
4. Foteinos G., Xu Q. 2009. Immune-mediated mechanisms of endothelial damage in atherosclerosis. Autoimmunity. 42, 627-633.
5. Topol E. J. 2006. The genetics of heart attack. Heart. 92, 855-861.
6. Casas J. P., Cooper J., Miller G. J., Hingorani1 A. D., Humphries S. E. 2006. Investigating the genetic determinants of cardiovascular disease using candidate genes and meta-analysis of association studies. Ann. Hum. Genetics. 70, 145-169.
7. Baudhuin L. M. 2009. Genetics of coronary artery disease: focus on genomewide association studies. Am. J. Transl. Res. 1, 221-234.
8. Spiridonova M. G., Stepanov V. A., Puzyrev V. P., Karpov R. S. 2002. Analysis of gene complexes predisposing to coronary atherosclerosis. Russ. J. Genet. 38, 300-308.
9. Dankovtseva E. N., Zateishchikov D. A., Chudakova D. A., Koroleva O. S., Brovkin A. N., Nosikov V. V., Gaidukova N. V., Tishchenko V. A., Sidorenko B. A. 2005. Association of hemostasis factor genes with early development of ischemic heart diseases and manifestations of myocardial infarction at young age. Kardiologiya. 45, 17-24.
10. Pchelina S. N., Sirotkina O. V., Sheidina A. M., Taraskina A. E., Rodygina T. I., Demina E. P., Zabotina A. M., Mitupova M. I., Bazhenova E. A., Berkovich O. A. 2007. Genetic factors of risk for development of myocardial infarction in young men living in northwestern Russia. Kardiologiya. 47, 29-34.
11. Voevoda M. I., Kulikov I. V., Maksimov V. N., Malyutina S. K., Schachtschneider E. V., Kulishova L. M., Novoselov V. P., Romashchenko A. G. 2009. Instant cardiac death and polymorphism of candidate genes for cardiovascular diseases. Kardiologiya. 49, 52-57.
12. Sirotkina O. V., Zabotina A. M., Berkovich O. A., Bazhenova E. A., Vavilova T. V., Shvartsman A. L. 2009. Genetic variants of platelet ADP receptor P2Y12 associated with changed platelet functional activity and development of cardiovascular diseases. Genetika. 45, 247-253.
13. Gukova S. P., Fomicheva E. V., Kovalev Yu. P. 1997. Role of structural polymorphism of the angiotensin-onverting enzyme in the development of myocardial infarction. Klin Med. 75, 36-39.
14. Berkovich O. A., Bazhenova E. A., Volkova E. A., Alugishvili M. Z., Kiselev I. O., Smirnov B. I., Shvarts E. I., Shlyakhto E. V. 2001. The I/D polymorphism of angiotensin-converting enzyme gene in young men with myocardial infarction. Ross. Fiziol. Zh. im. M. M. Sechenova. 87, 642-648.
15. Spiridonova M. G., Stepanov VA., Puzyrev V. P., Kosyankova T. V., Karpov R. S. 2001. Association between polymorphism T174M ofthe angiotensinogen gene and coronary atherosclerosis in the Tomsk population. Mol. Biol. 35, 11-14.
16. Nikitin A. G., Gorashko N. M., Minushkina L. O., Kudryashova O. Yu., Zateishchikov D. A., Sidorenko B. A., Nosikov V. V. 2003. Association of the G7831A polymorphism ofthe ACE gene with coronary heart disease in muscovites. Mol. Biol. 37, 49-51.
17. Babunova N. B., Minushkina L. O., Zateishchikov D. A., Sidorenko B. A., Nosikov V. V. 2003. Association ofthe T174M and M235T polymorphisms of the angiotensinogen gene with coronary heart disease in ethnic Russians from Moscow. Mol. Biol. 37, 52-55.
18. Sheidina A. M., Pchelina S. N., Demidova D. M., Rodygina Tl., Tarashkina A. E., Toperverg O. B., Berkovich O. A., Demina E. V., Shvarts E. I., Pogoda T. V., Generozov E. V., Govorun V. M., Lopukhin Yu. M., Shevchenko Yu. A. 2004. Analysis of allele frequencies of four single-nucleotide polymorphisms in the 50-untranslated region of the ABCA1 gene in young men with myocardial infarction. Kardiologiya. 44, 40-45.
19. Zateyshchikov D. A., Dankovtseva E. N., Nikitin A. G., Koroleva O. S., Brovkin A. N., Yakunina N. Yu., Chudakova D. A., Nosikov V. V., Sidorenko B. A. 2006. Genetic predisposition to early onset of coronary artery disease. Atherosclerosis. 7, S131.
20. Shevtsov S. P., Kuchinskii A. P., Dzeranova N. Ya., Ktsoeva T. V., Fomicheva K. V., Kovalev Yu. R., Shvarts E. I. 1994. Analysis of polymorphisms of apoB and apoC3 apolipoprotein genes in patients with myocardial infarction. Mol. Genet. Mikrobiol. Virusol. 3, 33-36.
21. Volkova M. V., Vasina V. I, Fomicheva E. V, Schwartz E. I. 1997. Comparative analysis of apo(a) gene alleles: Distribution of pentanucleotide repeats in position - 1373 and C/T transition in position +93 among patients with myocardial infarction and a control group in St. Petersburg, Russia. Biochem. Mol. Med. 61, 208-213.
22. Stepanov V. A., Puzyrev V. P., Karpov R. S., Kutmin A. I. 1998. Genetic markers in coronary artery disease in a Russian population. Hum. Biol. 70, 47-57.
23. Shagisultanova E. I., Mustafina O. E., Tuktarova I. A., Khusnutdinova E. K. 2001. HindIII polymorphism of lipoprotein lipase gene and the risk of myocardial infarction. Mol. Genet. Mikrobiol. Virusol. 3, 18-22.
24. Mustafina O. E., Shagisultanova E. I., Tuktarova I. A., Khusnutdinova E. K. 2002. Polymorphism of the apolipoprotein E gene and risk of myocardial infarction. Mol. Biol. 36, 792-797.
25. Voevoda M. I., Stepanov V. A., Romashchenko A. G., Maksimov V. N. 2006. Specific ethnogenetic features of susceptibility to atherosclerosis in ethnic groups of Siberia (the example of apolipoprotein E gene). Byull. Sib. Otd. Ross. Akad. Med. Nauk. 2, 63-72.
26. Kuz'mina A. A., Latfulin I. A. 1998. HLA haplotypes in young patients with myocardial infarction. Terapevt. Arkhiv. 70, 33-37.
27. Voevoda M. I., Ustinov S. N., Yudin N. S., Dolgikh M. M., Kuznetsova T. N., Maksimov V. N., Kulikov I. V., Gromov A. A., Shabalin A. V., Semaeva E. V., Kobzev V. F., Baum S. R., Gafarov VV, Malyutina S. K., Romaschenko A. G., Nikitin Y. 2002. Association of the CCR2 chemokine receptor gene polymorphism with myocardial infarction. Dokl. Biol. Sci. 385, 367-370.
28. Tereshchenko I. P., Petrkova J., Mrazek F., Lukl J., Maksimov V. N., Romaschenko A. G., Voevoda M. I., Petrek M. 2009. The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction. Clin. Chim. Acta. 402, 199-202.
29. Konenkov V. I., Rakova I. G., Maksimov V. N., Voevoda M. I. 2006. Allelic polymorphism of genes for pro-and anti-inflammatory cytokines in a Caucasoid male population. Byull. Sib. Otd. Ross. Akad. Med. Nauk. 2, 56-62.
30. Sambrook J., Fritsch E. F., Maniatis T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press.
31. He B., Navikas V., Lundah, J., Söderström M., Hillert J. 1995. Tumor necrosis factor alpha-308 alleles in multiple sclerosis and optic neuritis. J. Neuroimmunol. 63, 143-147.
32. Roth M. P., Nogueira L., Coppin H., Clanet M., Clayton J., Cambon-Thomsen A. 1994. Tumor necrosis factor polymorphism in multiple sclerosis: No additional association independent of HLA. J. Neuroimmunol. 51, 93-99.
33. Sandford A. J., Pare P. D. 1997. Direct PCR of small genomic DNA fragments from serum. Biotechniques. 23, 890-892.
34. DeMichele A, Martin A. M., Mick R, Gor R, Wray L., Klein-Cabral M., Athanasiadis G., Colligan T, Stadtmauer E., Weber B. 2003. Interleukin-6 174G3C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 63, 8051-8056.
35. Favorov A. V., Andreewski T. V., Sudomoina M. A., Favorova O. O., Parmigiani G., Ochs M. F. 2005. A Markov chain Monte Carlo technique for identification of combinations of allelic variants underlying complex diseases inhumans. Genetics. 171, 2113-2121.
36. O'Doherty C., Favorov A., Heggarty S., Graham C., Favorova O., Ochs M., Hawkins S., Hutchinson M., O'Rourke K., Vandenbroeck K. 2009. Genetic polymorphisms, their allele combinations, and IFN-beta treatment response in Irish multiple sclerosis patients. Pharmacogenomics. 10, 1177-1186.
37. Chikhladze N. M., Samedova Kh. F., Sudomoina M. A., Ko Min, Koliadina Yu. A., Litonova G. N., Favorov A. V., Chazova I. E., Favorova O. O. 2008. Comparative genetic analysis of different forms of Iow-renin arterial hypertension. Mol. Biol. 42, 521-530.
38. Favorova O. O., Favorov A. V., Boiko A. N., Andreewski T. V., Sudomoina M. A., Alekseenkov A. D., Kulakova O. G., Gusev E. I., Parmigiani G., Ochs M. F. 2006. Three allele combinations associated with multiple sclerosis. BMCMed. Genet. 26, e63.
39. Parfenov M. G., Titov B. V., Sudomoina M. A., Martynov M. Yu., Favorov A. V., Ochs M. F., Gusev E. I., Favorova O. O. 2009. Genetic susceptibility to ischemic stroke in Russians. Mol. Biol. 43, 873-880.
40. Ozaki K., Ohnishi Y., Iida A., Sekine A., Yamada R., Tsunoda T., Sato H., Sato H., Hori M., Nakamura Y., Tanaka T. 2002. Functional SNPs in the lymphotoxinalpha gene that are associated with susceptibility to myocardial infarction. Nature Genet. 32, 650-654.
41. Laxton R., Pearce E., Kyriakou T, Ye S. 2005. Association of the lymphotoxin-alpha gene Thr26Asn polymorphism with severity of coronary atherosclerosis. Genes Immun. 6, 539-541.
42. Clarke R., Xu P., Bennett D., Lewington S., Zondervan K., Parish S., Palmer A., Clark S., Cardon L., Peto R. 2006. Lymphotoxin-alpha gene and risk of myocardial infarction in 6928 cases and 2712 controls in the ISIS casecontrol study. PLoS Genet. 2, e107.
43. Auer J., Weber T, Berent R., Lassnig E., Lamm G., Eber B. 2003. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am. J. Pharmacogenomics. 3, 317-328.
44. Gonzalez R, Alvarez R., Batalla A., Reguero J. R., Alvarez V., Astudillo A., Cubero G. I., Cortina A., Coto E. 2001. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction. Genes Immun. 2, 191-195.
45. Barbaux S., Tregouet D. A., Nicaud V, Poirier O., Perret C., Godefroy T., Francomme C., Combadiere C., Arveiler D., Luc G., Ruidavets J. B., Evans A. E, Kee F., Morrison C, Tiret L., Brand-Herrmann S. M., Cambien F. 2007. Polymorphisms in 33 inflammatory genes and risk of myocardial infarction: A system genetics approach. J. Mol. Med. 85, 1271-1280.
46. Licastro F., Chiapelli M., Caldarera C. M., Caruso C., Lio D., Corder E. H. 2007. Acute myocardial infarction and proinflammatory gene variants. Ann. N. Y. Acad. Sci. 1119, 227-242.
47. Bis J. C., Heckbert S. R., Smith N. L., Reiner A. P., Rice K., Lumley T., Hindorff L. A., Marciante K. D., Enquobahrie D. A., Monks S. A., Psaty B. M. 2008. Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis. 198, 166-173.